{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:47:02Z","timestamp":1792640822621,"version":"4.5.0"},"reference-count":60,"publisher":"Royal College of Psychiatrists","issue":"6","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec id=\"S2056472425108302_as1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psychotic symptoms in depression are linked to worse outcomes, and treatment options are limited. Ketamine and esketamine are effective antidepressants, yet most studies have excluded patients with a history of psychotic symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472425108302_as2\">\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To evaluate by systematic review the efficacy and safety of ketamine and esketamine in treating patients with unipolar or bipolar depressive episodes with psychotic features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472425108302_as3\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A comprehensive search of the PubMed, Ovid and Web of Science databases was conducted up to 2 November 2023. We included any study that reported the use of ketamine or esketamine in patients with depressive episodes with psychotic symptoms. The primary outcomes assessed were variations in depressive and psychotic symptoms and the incidence of adverse events. The protocol was preregistered in PROSPERO (CRD42023488524).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472425108302_as4\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten studies were included, encompassing 60 patients with unipolar depression with psychotic symptoms and 19 patients with bipolar depression with psychotic symptoms. Treatment with (es)ketamine showed mean score changes on the Montgomery\u2013\u00c5sberg Depression Rating Scale ranging from \u221213.7 to \u221218.2 points in open-label studies of patients with unipolar depression with psychotic symptoms. Up to 50% of participants achieved remission. The largest study with patients with bipolar depression with psychotic symptoms reported a mean Montgomery\u2013\u00c5sberg Depression Rating Scale score change of \u221214.9 points. Adverse events were mostly mild and transient. There were no reports of switches to (hypo)mania or deterioration of psychotic symptoms, and in six studies there was substantial improvement of the latter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472425108302_as5\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The available evidence suggests that (es)ketamine shows antidepressant effects in patients with depressive episodes with psychotic features and has a reasonable safety profile. However, the heterogeneity of the studies included in this review and the high risk of bias warrant caution in interpreting the findings and underscore the need for further trials to confirm these preliminary results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1192\/bjo.2025.10830","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T09:37:02Z","timestamp":1760434622000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["(Es)ketamine as a treatment for depressive episodes with psychotic features: systematic review"],"prefix":"10.1192","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9926-3887","authenticated-orcid":false,"given":"Henrique Castro","family":"Santos","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0220mzb33","id-type":"ROR","asserted-by":"publisher"}],"name":"King\u2019s College London"},{"name":"Bethlem Royal Hospital"},{"name":"S\u00e3o Jos\u00e9 Local Health Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-9446","authenticated-orcid":false,"given":"Alexandra","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"S\u00e3o Jos\u00e9 Local Health Unit"},{"name":"Funchal Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8930-4382","authenticated-orcid":false,"given":"Tiago","family":"Machado","sequence":"additional","affiliation":[{"name":"University of Lisbon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6098-429X","authenticated-orcid":false,"given":"Manuel","family":"Gon\u00e7alves-Pinho","sequence":"additional","affiliation":[{"name":"University of Porto"},{"name":"T\u00e2mega e Sousa Local Health Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2291-6952","authenticated-orcid":false,"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0220mzb33","id-type":"ROR","asserted-by":"publisher"}],"name":"King\u2019s College London"},{"name":"Bethlem Royal Hospital"},{"name":"Imperial College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-3396","authenticated-orcid":false,"given":"Mario F.","family":"Juruena","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0220mzb33","id-type":"ROR","asserted-by":"publisher"}],"name":"King\u2019s College London"},{"name":"Bethlem Royal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"S2056472425108302_ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609"},{"key":"S2056472425108302_ref22","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120959644"},{"key":"S2056472425108302_ref17","first-page":"CD004044","article-title":"Pharmacological treatment for psychotic depression","volume":"2021","author":"Kruizinga","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"S2056472425108302_ref31","volume-title":"JBI Manual for Evidence Synthesis","author":"Moola","year":"2024"},{"key":"S2056472425108302_ref11","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.257"},{"key":"S2056472425108302_ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.08.041"},{"key":"S2056472425108302_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13284"},{"key":"S2056472425108302_ref14","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.122"},{"key":"S2056472425108302_ref39","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000852"},{"key":"S2056472425108302_ref41","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyab088"},{"key":"S2056472425108302_ref51","doi-asserted-by":"crossref","first-page":"115843","DOI":"10.1016\/j.psychres.2024.115843","article-title":"Clinical efficacy of adjunctive esketamine anesthesia in electroconvulsive therapy for major depressive disorders: a pragmatic, randomized, controlled trial","volume":"335","author":"Ren","year":"2024","journal-title":"Psychiatry Res"},{"key":"S2056472425108302_ref16","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0510"},{"key":"S2056472425108302_ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717002501"},{"key":"S2056472425108302_ref32","first-page":"2127","article-title":"Methodological quality of case series studies","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"S2056472425108302_ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.09.339"},{"key":"S2056472425108302_ref3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.11.1855"},{"key":"S2056472425108302_ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"S2056472425108302_ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.937996"},{"key":"S2056472425108302_ref59","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1325399"},{"key":"S2056472425108302_ref58","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m14336"},{"key":"S2056472425108302_ref60","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.90"},{"key":"S2056472425108302_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"S2056472425108302_ref42","first-page":"151","article-title":"Safety and efficacy of ketamine in a patient with psychotic depression, cardiovascular disease, and starvation risk","volume":"28","author":"Trejos Orozco","year":"2022","journal-title":"Rev M\u00e9d Risaralda"},{"key":"S2056472425108302_ref28","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"S2056472425108302_ref29","unstructured":"29 Wells, GA , Shea, B , O\u2019Connell, D , Peterson, J , Welch, V , Losos, M , et\u00a0al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. The Ottawa Hospital, 2015 (https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp)."},{"key":"S2056472425108302_ref9","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S29716"},{"key":"S2056472425108302_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.06.050"},{"key":"S2056472425108302_ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4693"},{"key":"S2056472425108302_ref12","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20997"},{"key":"S2056472425108302_ref20","doi-asserted-by":"publisher","DOI":"10.1177\/20451253231202723"},{"key":"S2056472425108302_ref52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/YCT.0000000000000365","article-title":"Effect of low dose of ketamine on learning memory function in patients undergoing electroconvulsive therapy\u2014a randomized, double-blind, controlled clinical study","volume":"33","author":"Chen","year":"2017","journal-title":"J ECT"},{"key":"S2056472425108302_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2017.08.012"},{"key":"S2056472425108302_ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-238135"},{"key":"S2056472425108302_ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0004867419883341"},{"key":"S2056472425108302_ref46","first-page":"97","article-title":"The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling","volume":"24","author":"Overall","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"S2056472425108302_ref19","doi-asserted-by":"publisher","DOI":"10.1177\/07067437241245384"},{"key":"S2056472425108302_ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1214972"},{"key":"S2056472425108302_ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0431-y"},{"key":"S2056472425108302_ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052964"},{"key":"S2056472425108302_ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.06.011"},{"key":"S2056472425108302_ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1067-3"},{"key":"S2056472425108302_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.05.016"},{"key":"S2056472425108302_ref54","doi-asserted-by":"publisher","DOI":"10.1159\/000511348"},{"key":"S2056472425108302_ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(17)31534-1"},{"key":"S2056472425108302_ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.07.003"},{"key":"S2056472425108302_ref7","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v12.i9.1204"},{"key":"S2056472425108302_ref44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/15622970801981606","article-title":"Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment","volume":"9","author":"M\u00f6ller","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"S2056472425108302_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00451-7"},{"key":"S2056472425108302_ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.10.051"},{"key":"S2056472425108302_ref56","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00243-3"},{"key":"S2056472425108302_ref34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/JCP.0000000000001571","article-title":"Esketamine for unipolar major depression with psychotic features: a retrospective chart review and comparison with nonpsychotic depression","volume":"42","author":"Souza-Marques","year":"2022","journal-title":"J Clin Psychopharmacol"},{"key":"S2056472425108302_ref23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0706743718773728","article-title":"An overview of animal models related to schizophrenia","volume":"64","author":"Winship","year":"2019","journal-title":"Can J Psychiatry"},{"key":"S2056472425108302_ref26","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20r13459"},{"key":"S2056472425108302_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00194-8"},{"key":"S2056472425108302_ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000284576"},{"key":"S2056472425108302_ref36","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2019.0028"},{"key":"S2056472425108302_ref47","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.25531"},{"key":"S2056472425108302_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.06.002"},{"key":"S2056472425108302_ref55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jad.2012.01.039","article-title":"The validity of the severity-psychosis hypothesis in depression","volume":"140","author":"\u00d8stergaard","year":"2012","journal-title":"J Affect Disord"},{"key":"S2056472425108302_ref5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.3.574"}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056472425108302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T09:37:05Z","timestamp":1760434625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056472425108302\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["S2056472425108302"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2025.10830","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e240"}}